Archive
The scientific programme will be designed by the International Scientific Committee with the full support of the International Advisory Boards, to feature the best international speakers and a wide programme of subject areas across the spectrum of Drug Discovery & Development in plenary and parallel session formats.
1st Edition
John C. Warner
Beyond Benign (US)
Luigi Stasi
Head of Discovery Chemistry at UCB (UK)
Vincent Bordas
Scientist at Novartis Institutes for BioMedical Research (FR)
Patrizio Mattei
Roche (CH)
Klaus Kuemmerer
University of Lüneburg (DE)
Michael Willis
University of Oxford (UK)
Michael K. Jensen
CEO & Co-founder Biomia (DK)
Werngard Czechtizky
AstraZeneca (SE)
Walter Cabri
University of Bologna (IT)
Margherita Brindisi
University of Naples (IT)
Yanlong Gu
Huazhong University of Science and Technology (CN)
Francesca Micoli
GSK Vaccine Institute for Global Health (IT)
Jack Li-Yang
Chen
Auckland University of Technology (NZ)